Other Knowledge Centres
Alzheimer's Disease
Arthritis
Asthma
Benign Prostatic Hyperplasia
Cholesterol
Chronic Myeloid Leukemia
Diabetes
Gastrointestinal Stromal Tumours
Hepatitis
(HPV) & Cervical Cancer
Hypertension
Insomnia
Lysosomal Storage Disorders
Men's Health
Meningitis
Migraine
Non-small Cell Lung Cancer
Ophthalmics
Opioids and Pain
Parkinson's Disease
Renal Anaemia
Thrombosis
Back to EPG Online
EPG Diabetes Knowledge Centre
Home
The Need For Insulin Analogues
Treatment Overview
Treatment Options
IDF 2005
Further Reading
Treatment Options
Long term Action
Dual Action
Short term Action
Product
NovoRapid
®
Action Profile
Treatment Guidelines
Prescribing Information
Product Benefits
Clinical Data
Suitable Devices
In pump therapy
References
NovoRapid
®
Product benefits
Superior postprandial control -
Read more
Improved long-term glycaemic control -
Read more
Benefits of insulin analogue basal-bolus therapy -
Read more
Reduced nocturnal hypoglycaemia -
Read more
Flexibility around meals -
Read more
Paediatric use -
Read more
Simple pen dosing -
Read more